Homeopathy 2023; 112(04): 288-290
DOI: 10.1055/s-0043-1768917
Letter to the Editor

Arsenicum album 30C: An Unlikely Source of Liver Toxicity

1   Scientist-III, Epidemic Cell, Central Council for Research in Homoeopathy, New Delhi, India
,
Anupriya Chaudhary
2   Scientist-II, Clinical Research, Central Council for Research in Homoeopathy, New Delhi, India
,
Ishant Arora
3   Department of Homoeopathy, Central Council for Research in Homoeopathy, New Delhi, India
,
Roja Varanasi
4   Scientist-III, Clinical Research, Central Council for Research in Homoeopathy, New Delhi, India
› Institutsangaben
Preview

The AYUSH system of medicine continues to play an integral role in the management of coronavirus disease 2019 (COVID-19) infection in India. Whilst several clinical research studies have indicated the possible beneficial effects of homeopathic Arsenicum album in COVID-19 infection, supporting the advisory for its use by the Ministry of AYUSH, India, the latter has faced a substantial amount of criticism from other systems of medicine based on biased observations and insufficient literature review.

Recently, the journal Cureus published a clinical case-series paper entitled “Dangerous Placebo during the COVID-19 Pandemic: A Series of Homoeopathic Arsenicum Album-Induced Liver Injury.”[1] The article presents three cases of acute liver injury, including one patient with underlying non-alcoholic steatohepatitis (NASH) cirrhosis who later died, apparently due to the consumption of Arsenicum album 30C for COVID-19 prevention. We examined the data presented and the claims of the Cureus paper, identifying several discrepancies and concerns in its content.



Publikationsverlauf

Eingereicht: 20. Januar 2023

Angenommen: 22. März 2023

Artikel online veröffentlicht:
16. Juni 2023

© 2023. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany